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ABSTRACT 
Executive function (EF) in this study will be explored in older 
healthy controls and Parkinson’s Disease patients, with regards 
to working memory (WM) in younger healthy controls. Past 
literature suggests a lack of understanding between EF, WM and 
impulsivity despite vast research that shows the relationship 
between these concepts are related to a multitude of negative 
behaviours such as substance abuse (Moeller et al., 2004), 
addiction (Zhou et al., 2014; 2016), and the development of 
impulsive-compulsive disorders (ICDs) in neurodegenerative 
diseases such as Parkinson’s (Foster et al., 2013). 
The present study intends to build on previous literature by 
investigating the relationship between the two variables in 102 
younger healthy controls, 196 older healthy controls, and 498 PD 
patients.  
Correlation analyses supported literature that suggests 
impulsivity is higher in younger participants and that the 
relationship between impulsivity and EF is different across age 
groups; however, previous assumptions that PD patients who 
have not yet begun medication will be less impulsive than age-
matched controls and therefore exhibit an altered relationship 
between their EF scores were not met. Future research should 
expand on data using unmedicated PD patients to better   
understand the relationship between impulsivity and EF, and the 
development of ICDs. 
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Introduction 
Executive function refers to a collection of top-down mental processes that are 
required for goal-directed behaviour (Shallice, 1982) and encompasses a group of 
cognitive skills that control inhibition, attention, working memory, and cognitive 
flexibility (Diamond, 2013). Due to the diverse nature of executive functions, the 
focus of research outside of Parkinson’s disease will largely be on working memory 
and its role in temporarily storing and managing incoming sensory information to 
carry out complex cognitive tasks (Baddeley and Hitch, 1974). Impulsivity, defined as 
swift action without forethought of conscious judgement (Hinslie, 1940), and its 
relationship with working memory is a widely researched concept within a range of 
clinical disorders such as substance abuse or addiction with a focus on the 
relationship between impulsivity and the deterioration of cognitive functions 
(Kalenscher et al., 2006; Verdejo-García, 2008).   
Within addiction research, evidence supports the current hypothesis that long-term 
drug use of cocaine and other psychostimulants that are dopamine agonists impair 
executive functions, specifically working memory and inhibition control – functions of 
which are mediated by the prefrontal cortex and limbic system (Dalley et al., 2007). 
Further evidence for cocaine and other stimulants such as methamphetamine 
affecting impulsivity and working memory is supported in reports of higher impulsivity 
scores on the Barratt Impulsivity Scale-11 (BIS-11) associated with decreased 
results on working memory tasks (Moeller et al, 2004; Albein-Urios et al., 2012; 
Sleigh et al., 2014; Minozzi et al., 2015). Additionally, the impact of methadone and 
ketamine use groups self-reporting higher impulsivity scores correlates with 
significantly lower working memory task results than a non-drug using control group 
(Zang et al., 2016), however research in this area also shows impulsivity acts as a 
vulnerability factor for engaging in substance abuse (von Diemen et al., 2008; 
Jentsch, 2009) so the true nature of whether impulsivity is a symptom or an effect of 
substance abuse is unclear and requires further research. 
Furthermore, impulsivity and working memory are explored within areas of addiction 
other than narcotic abuse. Alcohol-dependent patients and internet addictive 
individuals both tested similar scores in increased impulsivity and decreased working 
memory scores on the BIS-11, Wisconsin Card Sorting test and Digit Span (Zhou et 
al., 2014), while pathological gamblers presented with significantly higher scores of 
impulsivity and cognitive dysfunction than the control group (Zhou et al., 2016). Gunn 
and Finn (2013) theorised that reduced working memory capacity in any form may 
promote impulsivity, which in turn predisposes the participant to addiction. 
Despite the prominence of measuring impulsivity and working memory in addiction, 
the emphasis of research is based on how the two variables have a negative effect 
following substance abuse and how further research can inform vulnerability factors 
on people with impulsive characteristics (von Diemen et al., 2008; Stautz et al., 
2016). Research lacks the understanding of how impulsivity may affect working 
memory prior to the onset of an addiction.  
Another aspect of research that is often overlooked in this area is age and how 
impulsivity levels may affect working memory in different age ranges, and how 
impulsivity may change over the course of a lifetime. Focus of the research in this 
area is mainly concentrated on younger samples and discovering a relationship 
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between impulsive traits and related life outcomes (Tsukayama et al., 2013), health 
behaviours (Stautz et al., 2016), and substance use disorders (von Diemen et al., 
2008). Research that does offer perspective on impulsivity across the lifespan 
disregards the impact of working memory but offers a divided opinion on whether 
age impacts impulsivity. The majority of findings in this area suggest impulsivity 
levels start gradually decreasing in a linear pattern after preadolescence (Steinberg 
et al., 2008; Fino et al., 2014) and are supported by literature that infers dopamine 
(DA) gradually declines across the lifespan, and thus impulsive behaviours decline 
likewise (Nagel et al., 2008; Li et al., 2010; Rutledge et al., 2016; Abdulrahman et al., 
2017). However, both Nagel et al. (2008) and Li et al. (2010) only look at DA decline 
in regard to variations in DA gene signalling; while Rutledge et al. (2016) look at 
decreasing levels of DA in the hippocampus of their participants, ergo do not fully 
explore the declining dopamine hypothesis that suggests lower levels of impulsivity 
has a negative effect on working memory and executive function. Furthermore, a 
study that explores functional and dysfunctional impulsivity in a sample of older 
adults, aged 65 and above, found that elder participants had higher levels of 
dysfunctional impulsivity than young adults (Morales-Vives and Vigil-Colet, 2012). 
This inconsistency within the research supports further analysis of the effects of 
ageing on both impulsivity, working memory and executive function.  
Previous literature that explores the neurobiological basis of impulsivity holds 
inconclusive results as to which areas of the brain correlate with impulsive 
behaviours. Bickel et al (2007; 2012) argue that there are overlapping brain areas 
associated with an impulsive decision system embodied within the limbic and 
paralimbic brain regions that, within addiction, exhibit more control than the 
prefrontal cortex that is associated with executive function. However, Dichter et al. 
(2012) suggest a dysfunctional output of the nigrostriatal dopamine pathway that 
mediates the processing of rewards. Furthermore, the mesolimbic pathway that 
transports dopamine from the ventral tegmental area to the nucleus accumbens in 
the ventral striatum (Ikemoto, 2010) is attributed to detecting rewarding stimuli and 
reward hypersensitivity, both recognised as features of impulsivity (Martin and Potts, 
2004; Adinoff, 2007). Additionally, clinical research has associated damage to the 
orbital frontolimbic system with increased results in self-reported and behavioural 
measures of impulsivity in borderline personality disorder (Lieb et al., 2004; Berlin, 
2005; Kahnt and Tobler, 2017).  
Seemingly the specific neuroanatomy for impulsivity is still in question, as evidence 
suggests impulsivity is associated with a wide range of areas such as the 
nigrostriatal and mesolimbic pathways (Ikemoto, 2010; Dichter et al., 2012) and 
orbital frontolimbic cortex (Lieb et al., 2004; Berlin, 2005; Kahnt and Tobler, 2017). 
However, research agrees that underpinning each of the structures and pathways 
discussed is the neurotransmitter dopamine.  
In Parkinson’s disease (PD) research, a neurodegenerative disorder characterised 
by progressive nigrostriatal dopamine depletion (Callesen et al., 2014), the 
importance of DA is highlighted within impulsivity as using DA agonist replacement 
therapy exacerbates impulsive-compulsive behaviour in some patients (Pine et al., 
2010). Following the administration of medications such as Levodopa, that act as a 
precursor for dopamine, and Carbidopa, a DA agonist, literature shows a small 
percentage of patients are seen to develop impulse-control problems that extend to 
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compulsive gambling, shopping, eating, and hypersexuality (Weintraub et al., 2014). 
The use of DA precursor and agonist medications has shown to be largely 
successful in reducing the motor symptoms that are debilitating in PD that include 
bradykinesia, the slowness of muscle movement; tremors; rigidity; and gait issues 
(Vijverman and Fox, 2014). However, manipulating levels of DA within the ventral 
striatum is associated with an increased interest in obtaining rewards and novelty 
seeking (Leyton et al., 2002), and inducing the previously denervated nigrostriatal 
and mesolimbic systems with DA agonists accounts for increased behavioural 
fluctuations, including impulsivity (Thobias et al., 2010). Furthermore, prior to the 
onset of DA agonist medication use, results shows decreased levels of novelty 
seeking behaviour in PD patients potentially due to decreased dopamine volume 
(Raja and Bentivoglio, 2012). This association between impulsivity levels prior to 
dopamine medication administration suggests that the increase of impulsive 
behaviours is related directly to DA manipulation in some PD patients. 
In Parkinson’s disease research the focus of impulsivity is on the prevalence of 
impulsive-compulsive disorders (ICDs) that can be exhibited in a range of patients 
with limited understanding as to why. ICD figures range from 6% of Parkinson’s 
patients without, and 16-35% with, a dopamine agonist treatment (Papay et al., 
2011; Weintraub et al., 2012; Okai et al., 2016), yet despite knowledge of impulsive-
compulsive behaviours affecting approximately 10% of patients, it remains to be 
examined as to whether Parkinson’s disease itself is associated with impulsivity, or if 
it is the dopamine medication causing impulsivity issues.  
Past research has found the administration of dopamine agonists in young PD 
patients (average age of 45) who had never previously been medicated resulted in 
increased temperament changes in novelty seeking and reward dependence (Bódi et 
al., 2009). Impulsive decisions based on good outcomes also increased in medicated 
Parkinson’s patients compared to unmedicated (Frank et al., 2004) which suggests 
that if impulsivity increases after DA manipulation, those with higher levels of 
impulsivity prior to medication may be at risk of developing ICD’s. 
With respect to executive function in PD, assessment involves testing a patient’s 
cognitive performance throughout the duration of the disease from onset. The 
emphasis of research that is aimed at impulsivity and executive function in 
Parkinson’s patients is involved in locating the cognitive deficits a patient is 
experiencing and using progressive initiatives to assist patients and carers as the 
disease progresses (Woods and Tröster, 2003; Kudlicka et al., 2011) rather than 
understanding the relationship between the two constructs.  
The cognitive deficits known to correlate with PD prior to medication are executive 
function tasks such as task-set switching, visuospatial tasks, concept-formation, 
verbal fluency, memory recall and problem solving - all linked to fronto-executive 
activations mediated by the dorsal striatum (Balleine et al., 2007; Broeders et al., 
2013; Goldman et al., 2014). This disturbance has been suggested that mesocortical 
DA neurons originating from the ventral tegmental area affected in PD are not 
innervating the prefrontal cortex that is associated with executive function (Tassin, 
1997). Executive function capacity is also decreased following the use of dopamine 
medication in tasks such as inhibiting interfering stimuli and digit span tasks (Woods 
and Tröster, 2003) also due to the depletion of dopamine in the striatonigral and 
mesocortical DA systems of the frontal lobes (Sawamoto et al., 2008; Foster et al., 
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2013). This research supports how a dopamine deficiency effects executive function 
in PD patients, and with impulsivity also being underlined by DA, it solidifies the need 
for further research into how the two interact within PD patients who are on and off 
medication.   
Furthermore, cognitive deficits can be detected in early unmedicated patients 
(Santengelo et al., 2015), however, the means of testing these deficits are mixed. 
Research suggests that the sensitivity of cognitive tests such as the Letter-Number 
Sequencing and Digit Span tasks are unable to detect cognitive dysfunction in early 
PD patients (Schneider et al., 2010) with research advising clinicians to apply further 
tests before drawing conclusions of impaired executive function from these tasks 
(Egeland, 2015). However, information processing speed tested by the Symbol Digit 
Modality task has been appraised for its detected of impaired performance in PD 
(Benedict et al., 2017; Silva et al., 2018). The contrast in results for cognitive testing 
in PD shows that development into using tasks that detect dysfunction needs to be 
equal across all realms to aid diagnosis. 
Additionally, research in this area rarely evaluates the relationship between 
impulsivity and executive functions as a whole in Parkinson’s disease, unless 
combined with another factor such as depression (Foster et al., 2013), personality 
(Poletti and Bonuccelli, 2012), or the results of dopaminergic medication 
(Djamshidian et al., 2011; Papay et al., 2011), and there is no research on exploring 
executive function in impulsivity with Parkinson’s patients off medication. 
Furthermore, cognitive decline is common in elderly people (Winblad et al., 2004; 
Curerri et al., 2018), with deficits in executive function showing a consistent decline 
in both PD and older healthy controls (Leung et al., 2015), and an increase in 
cognitive impairments in baseline measures of PD patients diagnosed at an older 
age (Chaudhuri et al., 2005; Chaudhuri et al., 2006). These findings, along with 
Morales-Vives and Vigil-Colet’s (2012) impulsivity research in an increase of 
dysfunctional impulsivity in the elderly discussed above, highlights the need for an 
increase in research surrounding executive function and impulsivity in older healthy 
controls. Research is needed to better understand how these variables develop with 
age as added benefits to understanding how these variables interlink prior to the 
effects of Parkinson’s would aid average baseline results for a multitude of 
neurodegenerative diseases that involve cognitive testing, and in a non-clinical 
sample would build on previous recommendations of providing an index of age-
dependent cognitive performance in the elderly (Abdulrahman et al., 2017).   
Rationale 
Evidence throughout has highlighted the need for further research into how 
impulsivity and working memory interact pertaining to both advancing age and PD 
patients who are both on and off medication. Impulsivity has been significantly 
explored in addiction research, but its role is unclear as to whether it is a vulnerability 
factor for substance abuse or a symptom (von Diemen et al., 2008; Zang et al., 
2016), and lacks an understanding of how impulsivity may affect working memory 
prior to the onset of substance abuse. 
Likewise, in Parkinson’s research a consensus has still not been met as to whether 
impulsivity is associated as a symptom of PD or due to the dopaminergic medication 
(Djamshidian et al., 2011; Papay et al., 2011). There is also no research specifically 
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aimed at PD patients off medication with regards to the relationship between 
impulsivity and executive function. 
Furthermore, age in impulsivity and working memory research is explored in a limited 
capacity in that participants are usually of a younger age and is often studied without 
consideration for working memory. Despite inconsistencies within impulsivity levels 
in older age (Steinberg et al., 2008; Morales-Vives and Vigil-Colet, 2012) research is 
still limited in the area, and research that does consider working memory in age 
focuses on cognitive impairments (Leung et al., 2015) despite previous 
recommendations of providing an age-dependent cognitive performance index in the 
elderly (Abdulrahman et al., 2017).  
Aims 
To build on gaps in the research critiqued above, the aims of these study are three-
fold: 
 Assess whether impulsivity is altered in unmedicated, early-stage Parkinson’s 
disease patients. 
 Assess any changes in the relationship between impulsivity and executive 
functions in older Parkinson’s patients and healthy controls. 
 Assess the relationship between impulsivity and working memory in younger 
and older healthy controls to establish the link between the variables in an 
age-varying non-clinical sample. 
Hypothesis 
 H1: Participants with Parkinson’s disease who have not yet begun medication 
will be less impulsive than age-matched controls 
 H2: There will be an altered relationship between executive function ability 
and impulsivity in the PD group compared to the older healthy control group 
 H3: Younger participants will be more impulsive than older participants 
 H4: The relationship between executive function and impulsivity will be 
different across the age groups 
 
Methods 
Due to this study utilising data from the Parkinson’s Progression Markers Initiative 
(PPMI) quantitative database and real-world data collected, two methods sections 
have been created to give greater clarity on each aspect of the project. Methods I will 
inform the collection of real-world data, whilst Methods II will follow PPMI data 
collection regulations. 
Methods I 
Design 
This is a correlational study assessing impulsivity and working memory in a group of 
participants recruited through opportunity sampling in Manchester Metropolitan’s 
Research Participation Pool and from an announcement made on the researcher’s 
behalf in a Manchester Metropolitan Psychology society meeting. A modified online 
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digit span (Wechsler, 1997) was used to measure working memory, and impulsivity 
was tested on the Barratt Impulsivity Scale (Stanford et al., 2009). 
Participants 
A total of 118 participants, aged between 18-63, completed the online questionnaire 
and digit span. 16 participants were removed to reduce the maximum age to 29 for 
comparisons against the older healthy controls from the quantitative database, who’s 
ages started at 30. This left 102 participants aged 18-29, all of whom were healthy, 
with no known cognitive impairments. 
Measures 
Barratt Impulsivity Scale-11 
The Barratt Impulsivity Scale-11 (BIS-11) (APPX 1) consisted of 30 questions on a 
Likert scale of ‘Rarely/Never’ to ‘Almost Always/Always’ and was used to determine 
participant’s impulsivity score that included questions such as ‘I plan tasks carefully’ 
and ‘I say things without thinking’. These scores were totalled for overall impulsivity. 
The BIS-11was found to have high internal reliability (α = .83). 
Digit Span 
Executive function was, in this instance, tested on working memory through a 
modified online digit span (APPX 2). Participants were presented with instructions on 
how to answer and were given two attempts at a 3-digit forward practise, and 3-digit 
reverse practise, before beginning each marked attempt. 
Each sequence of digits was generated using an online random number generator 
(Hedges, 2018). Using Qualtrics (2018), 3 digits were first presented to participants 
‘7-3-9’, followed by a series of 4 digits that increased by 1 number each correct 
answer until it reached a sequence of 9 digits altogether. During the first round of 
sequences the participants were asked to report the digits exactly as they appeared 
and would be sent to the reverse digit span section if two incorrect attempts were 
made.  
Following the first round of digits, participants were then asked to repeat the process 
but report the digits in reverse to the sequence they had seen, so the correct answer 
for ‘3-9-6’ would be ‘6-9-3’, and so on until 9 digits. The total score for digit span 
results were points for the highest number sequenced reached, with 2 points 
awarded per digit for a correct answer on the first attempt, and 1 point awarded per 
digit for a correct answer on the second attempt. 
Permission was sought through email for the use of the BIS-11 and digit span test. 
Procedure 
Participants who applied through the MMU participation pool and MMU Psychology 
Society were provided with an invitation letter (APPX 3) and those who proceeded to 
the study were provided with further information in the participant information sheet 
(APPX 4) and agreed to terms of a consent form (APPX 5) that detailed what the 
study entailed. Age was recorded as a measure for later analysing the results, 
followed by the BIS-11, and then the forward and reverse digit span. Once all tasks 
were completed, a debrief sheet (APPX 6) was provided to reiterate aims of the 
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study to participants and provide an anonymous code generator which they were 
required to fill in if they wished to withdraw from the study at a later date, or request 
research details. 
Analysis 
All analysis was completed using SPSS (Version 24). On the younger healthy 
controls, a correlation analysis was carried out to test the relationship between 
impulsivity and working memory using total scores from the BIS-11 and total digit 
span, and a Fisher’s r-to-z test was carried out to compare correlations between 
impulsivity and working memory from the younger healthy control to their older 
healthy control equivalents. Lastly, a Fisher’s exact test was used to calculate the 
difference in impulsivity scores between younger and older healthy controls. (APPX 
11)  
Ethical considerations 
The research conducted in this study adhered to the guidelines stated by the British 
Psychological Society (2009) and was reviewed by the Department of Psychology 
Ethics Panel and approved by the Faculty of Health and Social Care Research 
Ethics Committee at Manchester Metropolitan University, ergo following all correct 
procedures with regard to consent, confidentiality, debriefing, and deception (APPX 
7). 
Vulnerable participants were not involved in this study as all were over the age of 18 
and were of sound mind and ability to give consent following the provision of study 
information. Each participant was provided with the necessary information prior to 
completion of the study, agreed to the terms of a consent form which listed the 
study’s aims and their right to withdraw, and a debrief was provided upon completion 
of the questionnaires and test. A code generator was provided for anonymity in the 
data, all of which was stored in compliance with the Data Protection Act (1998). 
Methods II 
Data used in the preparation of this article were obtained from the Parkinson’s 
Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data). For up-to-
date information on the study, visit www.ppmi-info.org.  
Design 
The PPMI study is a 5-year longitudinal study funded by the Michael J. Fox 
Foundation (MJFF) and industry partners with an overarching aim to identify one or 
more biomarkers of Parkinson’s disease progression using brain imaging, clinical 
evaluations, and biospecimen data (PPMI, 2017). 
Participants 
A total of 694 participants were collected in the PPMI database; 498 Parkinson’s 
disease patients (PD) and 196 older healthy controls, aged between 30-84 years old. 
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Measures 
Tests used from the PPMI database included the following tests: Questionnaire for 
Impulsive-Compulsive Disorders (QUIP) (APPX 8), Letter-Number Sequencing 
(APPX 9), and Symbol Digit Modalities (APPX 10).  
Procedure  
Each procedure was carried out subject to the guidelines highlighted in the study 
protocol, available to read at http://www.ppmi-info.org/study-design/research-
documents-and-sops/.  
Analysis 
A correlation analysis was carried out in both the older healthy controls and PD 
patients to test the relationship between impulsivity using the QUIP and executive 
function using Letter-Number Sequencing and Symbol Digit modality scores. 
An analysis of variance was performed on older healthy controls and PD patients 
following the creation of two groups from QUIP scores – those who showed evidence 
of an impulsive issue and those who did not – in both Letter-Number Sequencing 
and Symbol Digit modality scores. A Fisher’s Z-test was carried out on older healthy 
controls and PD patients to compare the correlation between each group’s 
impulsivity scores on the QUIP and executive function scores on Letter-Number 
Sequencing and Symbol Digit modality tasks.  
Finally, an independent t-test was performed on older healthy controls and PD 
patient to test for differences in impulsivity between the groups.  
Ethical Consideration 
The data collected in this study was performed in accordance with the Good Clinical 
Practise and the International Conference on Harmonization guidelines, as well as 
any applicable national and local regulations (Parkinson’s Progression Markers 
Initiative, 2017). Each participant gave informed consent, and anonymity is enforced 
through patient code numbers.  
Results 
Descriptive statistics were created for the participants in both the younger healthy 
control sample, and data collected from the Parkinson’s Progression Markers 
Initiative (PPMI) database. Table 1 summarises the demographics of younger 
controls with their scores on the digit span and impulsivity test. The average age of 
younger healthy controls was 24 years old. 
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*Total correct out of 14 
**Total correct out of 28 
 
Table 2 summarises the demographics of older healthy controls and patients with 
Parkinson’s disease (PD) with impulsivity scores, and two executive functions tasks. 
The average age for age for older healthy controls was 60 years old, and average 
age for PD patients was 61.  
 
Table 2     
Age, Impulsivity and Cognitive Scores in Older Healthy Controls and PD 
Patients 
    
Older Healthy 
controls   PD 
    (n=196)   (n=498) 
Age (years)  60.00 (11.17)  61.00 (9.83) 
Questionnaire for 
Impulsive-Compulsive 
Disorders  0.32 (0.78)  0.40 (2.72) 
Letter-Number Sequencing*  11.76 (2.73)  11.37 (10.04) 
Symbol-Digit Modality**   46.75 (10.50)   41.16 (9.83) 
*Total score out of 21 
**Total score out of 110 
 
 
Table 1     
Age and Cognitive Scores in Younger Healthy Controls  
    Mean   
Standard 
Deviation 
    (n=118)   (n=118) 
Age (years)  24.00  8.74 
Forward Digit Span*   9.26  3.09 
Reverse Digit Span*  6.90  4.34 
Total Digit Span**  16.16  6.41 
Barratt Impulsivity 
Scale-11   76.36   11.06 
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Correlational analysis 
Multiple bivariate Spearman’s correlations were carried out to test for relationships 
between impulsivity and executive function. In younger healthy controls, correlations 
were tested between impulsivity and digit span scores, the results of which can be 
seen in Table 3.  
Table 3 
     
Correlation analysis 
    
      
Forward 
Digit Span 
Reverse 
Digit Span 
Total 
Digit 
Span Control variable   
Barratt Impulsivity Scale-
11 (BIS-11) Total 
p 
Rho 
0.85 
0.02 
0.48 
-0.07 
0.69 
-0.04 
 
For older healthy controls and PD, correlations were tested between impulsivity, 
Letter-Number Sequencing and Symbol Digit modality scores. The results of which 
can be seen in Table 4.  
 
 
 
 
 
Table 4 
    
Correlation analysis 
  
      Letter Number 
Sequencing 
Symbol Digit 
Modality Control variables   
Questionnaire for 
Impulsive-Compulsive 
Disorders Total 
Older 
HC p 0.15 0.50 
  
Rho -0.10 -0.05 
  
PD 
Patients 
 
p 
Rho 
0.34 
-0.04 
0.51 
-0.03 
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The scatter diagrams above have been provided as an example of the lack of 
correlation between test scores in younger healthy controls, older healthy controls 
and PD patients. The results from the correlations revealed that the relationships 
between impulsivity and executive function were not significant for either younger 
healthy controls (rs(118) = -0.04, p = 0.69), older healthy control’s Letter Number 
Sequencing scores (rs(195) = -0.10, p = 0.15), older healthy controls Symbol Digit 
Modality scores (rs(195) = -0.05, p = 0.50), PD patient’s Letter Number Sequencing 
scores (rs(493) = -0.04, p = 0.34) or PD patient’s Symbol Digit Modality scores 
(rs(493) = -0.03, p = 0.51). 
Fisher’s Z-tests were carried out on the correlation coefficients that resulted from the 
correlations between impulsivity and executive function scores in the three groups 
(YHC, OHC and PD) in order to test whether these were significantly stronger in any 
of the groups compared with the others.  The coefficients on the correlation 
computed between younger healthy controls Letter-Number Sequencing and Symbol 
Digit modality scores were significantly higher than those in older healthy controls 
(Letter-Number Sequencing: z = 2.69, p<0.001; Symbol Digit modality: z = 3.14, 
p<0.001) and PD patients Letter-Number Sequencing: z = -0.01, p = 0.99; Symbol 
Digit modality: z = -0.10, p = 0.92). Comparisons between older healthy controls and 
PD patients were not significant (Letter-Number Sequencing: z = -1.74, p = 0.08; 
Symbol Digit modality: z = -0.02, p = 0.83). 
Furthermore, an independent t-test was performed on older healthy controls and PD 
patients to test whether there was a difference in impulsivity between the two groups, 
with no significant difference found (t(432.84) = -1.06, p = 0.29: 95% CI: -0.74-0.07).  
Finally, to compute impulsivity scores between younger and older healthy controls, 
BIS-11 scores ≥ 74 (Patton et al., 1995; Stanford et al., 2009) and QUIP scores ≥ 8 
(Weintraub et al., 2009) were coded ‘1’ for high impulsivity, and anything below these 
scores were ‘0’ for no impulsivity. A Fisher’s exact test was used to calculate 
differences in impulsivity between the two groups; there was a significantly greater 
proportion of younger healthy controls with high impulsivity (measured by the BIS-
11) than older healthy controls with high impulsivity (measured by the QUIP), 
p>0.001: 95% CI 0.12-0.21. 
Figure 1.1: Scatterplot showing 
the correlation in younger 
healthy controls impulsivity and 
executive functions 
Figure 1.2: Scatterplot showing 
the correlation in older healthy 
controls impulsivity and Letter-
Number sequencing scores 
Figure 1.3: Scatterplot showing 
the correlation in PD patients 
impulsivity and Symbol Digit 
modality scores 
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Comparison between PD patients with and without evidence of an impulsivity 
issue 
The PD and older healthy controls groups were classified as either with impulsivity 
issues (QUIP > 1) or without (QUIP = 0). The subsequent bar charts illustrate the 
comparisons of whether participants exhibited impulsivity issues in older healthy 
controls and Parkinson’s disease patient’s in executive functioning task scores.  
  
 
 
 
 
 
 
 
 
 
 
Analysis of Variance 
Two 2x2 independent ANOVA’s were conducted; Letter-Number sequencing scores 
were used as the first dependent variable, and Symbol Digit modality scores as the 
second. The two independent variables were patient grouping: older healthy control 
or PD patient; and whether or not there was evidence of impulsivity issues as the 
second variable.  
Results showed there were no significant differences in Letter-Number Sequencing 
scores between PD and older healthy controls (F(1, 680) = 0.76, p = 0.38) nor were 
results of those between participants with and without evidence of an impulsivity 
issue (F(1,680) = 2.79, p = 0.10).  
Symbol Digit modality scores between PD patients and older healthy controls were 
significantly different (F(1,680) = 23.68, p<0.001), however differences between 
participants with and without evidence of an impulsivity issue were not significant 
(F(1, 680) = 0.47, p = 0.49). 
Furthermore, interactions between participant grouping (PD and older healthy 
controls) and evidence of impulsivity issues (QUIP>1 with, QUIP=0 without) were 
insignificant in both Letter-Number Sequencing test (F(1,680) = 0.87, p = 0.35) and 
Symbol Digit Modality (F(1,680) = 0.33, p = 0.57). 
Discussion 
The current study aimed to investigate the relationship between impulsivity and 
scores on tasks measuring working memory in younger healthy controls, and 
Figure 2.1: Bar chart showing letter 
number sequence results in 
participants with and without evidence 
of an impulsivity issue 
Figure 2.2:  Bar chart showing symbol 
digit modality results in participants 
with and without evidence of an 
impulsivity issue 
Figure 2.1: Bar Chart illustrating 
mean Letter Number Sequencing 
scores across older participants 
impulsivity grouping 
Figure 2.1: Bar Chart illustrating 
mean Symbol Digit Modality 
scores across older participants 
impulsivity grouping 
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executive function in older healthy controls, and Parkinson’s disease (PD) patients. 
The results of this study did not support the aim of assessing whether impulsivity is 
altered in unmedicated PD patients following an insignificant t-test between PD and 
older healthy controls impulsivity scores. Analysis of Fisher’s Z-tests showed no 
significant relationship between executive function scores and impulsivity in PD 
patients, contrary to previous research that showed cognitive deficits could be 
identified in early unmedicated patients (Santengelo et al., 2015). Therefore, the two 
hypotheses that predicted PD patients would be less impulsive than age-matched 
controls and that there would be an altered relationship between executive function 
ability and impulsivity in the PD group compared to the older healthy control group 
were rejected. 
Conversely the hypothesis that younger healthy controls would be more impulsive 
than older participants was accepted as there was a significantly greater proportion 
of younger healthy controls with high impulsivity (measured by the BIS-11) than older 
healthy controls with high impulsivity (measured by the QUIP) that supported 
previous research (Steinberg et al., 2008; Fino et al., 2014). Fisher’s Z-test between 
younger and older healthy controls supported the third aim of assessing the 
relationship between impulsivity and executive function in younger and older healthy 
controls to establish the link between the variables in an age-varying non-clinical 
sample, as well as adding to previous impulsivity research by including executive 
function scores within this. Consequently, the hypothesis that the relationship 
between executive function and impulsivity would be different across the age groups 
was accepted following Fisher’s Z-tests between younger and older healthy controls 
impulsivity and working memory correlations that showed significant variances in 
executive function and impulsivity between younger and older healthy controls.  
Limitations 
Limitations in this study arose predominantly from the differences between data 
collection from the younger healthy control sample, and data collated from the 
Parkinson’s Progression Markers Initiative’s quantitative database. Large differences 
in sample size between younger (n=102) and older (n=196) healthy controls, and PD 
patients (n=498) meant equal representation for all participants was unavailable. 
Additionally, impulsivity measures for both groups were based on self-report scales 
that meant there was no objective measure for impulsivity, and response bias may 
have occurred depending on whether participants considered impulsivity a positive 
or negative attribute.  
Evidence of working memory being attributed to higher learning (Ghani and 
Gathercole, 2013; Cowan, 2014) may also have influenced working memory results 
in the younger healthy controls as the majority of participants were recruited through 
Manchester Metropolitan University’s student participation pool.  
In addition to sample bias, executive function tests administrated to the younger 
healthy control group, older healthy controls and PD patient group were different due 
to time restrictions on the collection of data for younger healthy controls. Older 
healthy controls and PD patients completed the Letter-Number Sequencing and 
Symbol Digit Modality to test for executive function, whereas younger healthy 
controls completed the Digit Span. Although all the tasks test executive function, 
Digit Span specifically tests working memory, whilst the Letter-Number Sequencing 
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and Symbol Digit modality do not test the same areas of executive function equally. 
Furthermore, research highlighted in the introduction suggests the Letter-Number 
Sequencing and Digit Span tasks specifically require further development and 
additional tests before conclusions regarding impaired executive function can be 
drawn (Schneider et al., 2010; Egeland, 2015).  
A final restriction on results is attribution of causality. Throughout this study it has 
been implied that executive function deficits stem from impulsivity due to past 
literature (Moeller et al, 2004; Albein-Urios et al., 2012; Sleigh et al., 2014; Minozzi et 
al., 2015), however impulsivity may stem from executive function deficits. 
Applied Implications 
Despite the limitations discussed above, the present study adds to current 
developing research in an area presently lacking in data. Results have added to 
understanding the dynamic nature of the relationship between impulsivity and 
executive function by highlighting a greater correlation in younger healthy samples 
outside of current addiction literature (von Diemen et al., 2008; Stautz et al., 2016). 
The data collected can also be used to add to recommendations of an age-
dependent cognitive performance index in the elderly (Abdulrahman et al., 2017) and 
potentially drive an initiative of examining data in unmedicated PD patients to better 
understand the relationship between impulsivity and executive function. 
Future Research 
The results of this study provide a good foundation for a number of directions for 
future research. The literature on impulsivity in PD patient’s notes a lack of 
understanding in how impulsive-compulsive disorders develop, so further research 
from the data of unmedicated PD patients in this study could involve a longitudinal 
study with a specific focus on how impulsive behaviours develop in unmedicated PD 
to impulsive-compulsive disorders. Alongside this, healthy controls could be used to 
add to research in how impulsivity changes across the lifespan, especially in the 
elderly.  
With regards to the previous critique of sample size differences, an increase of 
healthy control participants would be of benefit in the collection of data for the 
recommendation of age-matched cognitive scores in elderly participants 
(Abdulrahman et al., 2017). 
Future work in the sensitivity of tests in executive function and working memory, 
taking into account the limitations acknowledged in Letter-Number Sequencing and 
Digit Span tasks (Schneider et al., 2010; Egeland, 2015) has potential to aid 
diagnosis in numerous neurodegenerative diseases, aside from Parkinson’s, as 
cognitive deficits would be noticed earlier. 
Additionally, addiction research highlighted the lack of understanding of how 
impulsivity and working memory relate to one another prior to substance abuse. 
Given that results in this study support higher levels of impulsivity in younger healthy 
controls (Tsukayama et al., 2013), future work in addiction has the supporting 
evidence to cultivate preventative initiatives aimed at targeting younger impulsive 
individual’s that are vulnerable to developing addictive behaviours (von Diemen et 
al., 2008; Gunn and Finn, 2013). 
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Lastly, research into dopaminergic pathways relating to impulsivity were unable to be 
studied in this piece of work due to methodological restrictions, however literature 
shows extensive contradictions in the neurobiological underpinnings of impulsivity. 
Building on from this study’s supporting results of impulsivity changing across the 
lifespan, knowledge of the neurological basis of impulsivity can assist in 
understanding the development of impulsive-compulsive disorders.  
Conclusion 
To conclude, the present study has explored the relationship between impulsivity 
and executive function in relation to age and Parkinson’s disease. The current 
findings from both samples that belong to real-world collected data and the PPMI 
quantitative database support aspects of current research that indicates impulsivity is 
higher in a younger age and that the relationship between impulsivity and executive 
function is altered across age groups. On the contrary, findings did not support lower 
levels of impulsivity in early stage unmedicated Parkinson’s patients or differences in 
the relationship between impulsivity and executive function in PD patients or age-
matched controls. This highlights the need for further development of cognitive 
dysfunction sensitivity in assessment tools for PD diagnosis as recommended by 
past research (Leung et al., 2015), as well as adding to previous literature on 
providing data for an age-dependent cognitive performance index in the elderly 
(Abdulrahman et al., 2017). Additionally, suggestions have been made for future 
research to improve our understanding of the relationship between impulsivity and 
executive function, and how this can benefit primarily older healthy adults and early 
unmedicated Parkinson’s disease patients. 
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